Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - OTHER LONG-TERM ASSETS
Other Long-term Assets KALV - KalVista Pharmaceuticals, Inc.
567 K
LAST VALUE
71.40%
2 YEAR CAGR
26.80%
5 YEAR CAGR
16.80%
10 YEAR CAGR